Herein we report that ApoE−/− mice are significantly protected against cerebral malaria, and that pharmacological inhibition of ApoE using heparin octasaccharide (OCTA) could represent a new avenue in the development of adjunctive therapies for cerebral malaria. Here, APOE is linked to cerebral malaria.